Q4 2022 VolitionRX Ltd Earnings Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's full-year 2022 earnings conference call. During today's presentation, all parties will be in listen-only mode. (Operator Instructions) This conference is being recorded today, March 16, 2023.
I'd now like to turn the conference call over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead.
Thank you, and welcome, everyone to today's earnings conference call for VolitionRx Limited. This call will cover Volition's financial and operating results for the full-year 2022, along with a discussion of our recent activities and key upcoming milestones.
Following our prepared remarks, we will open the conference call to a question-and-answer session. Also on our call today are Mr. Cameron Reynolds, President and Group Chief Executive Officer; Mr. Terig Hughes, Group Chief Financial Officer; and Dr. Tom Butera, Chief Executive Officer of our Volition veterinary subsidiary.
Before
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |